We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+11.42%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$11.6B
AUM Growth
+$243M
(+2.1%)
Cap. Flow
-$770M
Cap. Flow
% of AUM
-6.61%
Top 10 Holdings %
Top 10 Hldgs %
17.24%
Holding
303
New
50
Increased
66
Reduced
133
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$102M |
| 2 |
S&P Global
SPGI
|
+$82.9M |
| 3 |
Intercontinental Exchange
ICE
|
+$72.4M |
| 4 |
Nike
NKE
|
+$55.5M |
| 5 |
Avery Dennison
AVY
|
+$49.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$95.4M |
| 2 |
TJX Companies
TJX
|
+$94.8M |
| 3 |
Chubb
CB
|
+$87.2M |
| 4 |
Intel
INTC
|
+$80.1M |
| 5 |
Union Pacific
UNP
|
+$73.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.27% |
| 2 | Technology | 17.63% |
| 3 | Consumer Discretionary | 13.42% |
| 4 | Industrials | 12.91% |
| 5 | Communication Services | 12.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Fortinet
FTNT
$119B
| $54.7M | 0.47% |
7,131,790
-2,254,905
| -24% | -$15.9M |
|
|
RHT
77
DELISTED
Red Hat Inc
RHT
| $54.7M | 0.47% |
632,286
-94,674
| -13% | -$7.52M |
|
|
SEE
78
DELISTED
Sealed Air
SEE
| $52.2M | 0.45% |
1,196,755
+249,785
| +26% | +$11.7M |
|
79
Bread Financial
BFH
$4.37B
| $52.1M | 0.45% |
262,387
+134,340
| +105% | +$25.4M |
|
80
MSCI
MSCI
$41.6B
| $51.9M | 0.45% |
533,829
-147,165
| -22% | -$13.3M |
|
|
81
Avery Dennison
AVY
$13B
| $51.5M | 0.44% |
+638,946
| New | +$49.6M |
|
82
Neurocrine Biosciences
NBIX
$16.8B
| $51.3M | 0.44% |
1,185,483
-208,022
| -15% | -$8.91M |
|
83
Axalta
AXTA
$7.66B
| $51M | 0.44% |
1,585,375
-302,435
| -16% | -$8.98M |
|
|
CAVM
84
DELISTED
Cavium, Inc.
CAVM
| $49.9M | 0.43% |
695,915
+380,165
| +120% | +$25.4M |
|
85
Lumentum
LITE
$55.5B
| $49.7M | 0.43% |
932,275
+466,085
| +100% | +$20.6M |
|
|
SPLK
86
DELISTED
Splunk Inc
SPLK
| $48M | 0.41% |
770,427
+9,442
| +1% | +$565K |
|
|
MSCC
87
DELISTED
Microsemi Corp
MSCC
| $47.3M | 0.41% |
918,736
-181,262
| -16% | -$9.73M |
|
|
TSS
88
DELISTED
Total System Services, Inc.
TSS
| $47.1M | 0.4% |
881,578
-166,818
| -16% | -$8.9M |
|
89
Quest Diagnostics
DGX
$25.7B
| $47.1M | 0.4% |
479,334
-210,847
| -31% | -$20.1M |
|
|
JBTM
90
JBT Marel
JBTM
$7.21B
| $45.1M | 0.39% |
512,802
-96,573
| -16% | -$8.37M |
|
91
East-West Bancorp
EWBC
$17.9B
| $44.7M | 0.38% |
866,439
-186,723
| -18% | -$9.8M |
|
|
KLXI
92
DELISTED
KLX Inc.
KLXI
| $44.2M | 0.38% |
1,173,084
+852,579
| +266% | +$34.4M |
|
|
WP
93
DELISTED
Worldpay, Inc.
WP
| $44.1M | 0.38% |
687,110
-41,835
| -6% | -$2.66M |
|
|
ALXN
94
DELISTED
Alexion Pharmaceuticals
ALXN
| $43.6M | 0.37% |
+359,212
| New | +$46.3M |
|
95
Builders FirstSource
BLDR
$7.15B
| $42.1M | 0.36% |
2,824,169
-536,987
| -16% | -$6.94M |
|
96
Progressive
PGR
$123B
| $41.9M | 0.36% |
+1,069,907
| New | +$40.8M |
|
97
Valero Energy
VLO
$90.1B
| $41.8M | 0.36% |
629,966
-15,617
| -2% | -$1.05M |
|
|
K
98
DELISTED
Kellanova
K
| $41.1M | 0.35% |
603,101
-62,676
| -9% | -$4.33M |
|
99
Nice
NICE
$5.79B
| $40.9M | 0.35% |
601,536
+231,513
| +63% | +$15.9M |
|
100
Monster Beverage
MNST
$94.3B
| $40.4M | 0.35% |
+1,750,790
| New | +$39.1M |
|
Similar funds
OAG
JG
CHP
SAM
Westfield Capital Management's Q1 2017 Portfolio in Review
As of Q1 2017, Westfield Capital Management held 303 positions worth $11.6B, up 2.1% from $11.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Westfield Capital Management withdrew a net $770M in Q1 2017, closing 45 positions and reducing 133 holdings. Its most notable exit was TJX Companies, an estimated $94.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Westfield Capital Management opened a new position in Biogen worth $98.2M.
- Westfield Capital Management's largest Q1 2017 buy was Biogen: 359,107 shares worth $98.2M.
- Westfield Capital Management added most to Walt Disney in Q1 2017, an estimated $48.8M increase.
- Westfield Capital Management's biggest Q1 2017 reduction was Gilead Sciences, cutting an estimated $95.4M.
- Westfield Capital Management fully exited TJX Companies in Q1 2017, selling an estimated $94.8M.
- Westfield Capital Management's ten largest holdings make up 17% of its $11.6B portfolio in Q1 2017.
- Westfield Capital Management opened 50 new positions and closed 45 in Q1 2017.
- Westfield Capital Management's portfolio value rose 2.1% quarter-over-quarter to $11.6B.
Based on Westfield Capital Management's 13F filing for Q1 2017, filed 12 May 2017.